Services
Platform
Technology & Data
About Us
Media Center
Contact
Careers
Breast
Cervical
Esophageal
HER2 Positive
Lung
Lymphoma
Melanoma
Myelofibrosis
Pancreatic
Pediatric
Prostate
Biomarker Ultimate Guide
All
Blog
Cancer
Glossary
Guides
Infographics
Magazine
News
Newsletter
Quizzes
Video
Webinar
Myelofibrosis (MF) is an uncommon bone marrow cancer that disrupts the body’s normal production of blood cells and causes scarring in the bone marrow.
We Provide Advanced Technology-Enabled Oncology Clinical Trial Services
We believe every cancer patient deserves the best chance to receive world-class healthcare options.
Contact Us What is Our Virtual Command Center?I am interested in
Clinical Trial Matching
All cancer patients deserve equal access to the latest in cancer care therapies and treatments. Refer a patient, friend, family member or loved one to get in touch with Massive Bio.
Refer a Patient
Pre-Screening
Massive Bio can improve your efficiency and patient satisfaction scores by pre-screening all cancer patients at your practice, at no cost to you. Patients are pre-screened with AI based technology for trials and advanced care options with sub-specialist and case management support.
Pre-screen Patients
Be Part of Our Oncologist Network
Join our growing network of key opinion leaders and oncologists. Your knowledge, research, and expertise in cancer treatment can make a difference.
Join Our Physician NetworkOther services we provide
Just In Time Activation
Multi-disciplinary background of experts like surgeons, radiation oncologists, pathologists, and medical oncologists gather to discuss treatment options for individual cancer patients.
EMR Activation
Instant access to patient EMR lets trial sites receive lab results, radiology reports, and even X-ray images electronically while ensuring tests are not duplicated. Machine learning technology for scaled pre-screening; prescreening in the matter of seconds instead of hours. Submit patient records digitally to expedite the pre-screening for the Synergy-AI clinical trial matching process.
Browse Recruiting Trials
Myelofibrosis (MF)
+18
Male & Female
Follicular Lymphoma (FL)
Follicular lymphoma (FL) is a very slow-growing cancer that may appear in your lymph nodes, your bone marrow and other organs.
Diffuse Large B Cell Lymphoma (DLBCL)
Diffuse large B cell lymphoma (DLBCL) is an aggressive type of non-Hodgkin lymphoma that can arise in lymph nodes or outside of the lymphatic system.
Mantle Cell Lymphoma (MCL)
Mantle Cell lymphoma (MCL) is an aggressive, rare form of non-Hodgkin lymphoma (NHL) that arises from cells originating in the “mantle zone.”
Cutaneous Melanoma (CM)
Cutaneous melanoma (CM) is cancer that starts in the pigment-making cells of the skin.
Esophageal Cancer (EC)
Esophageal cancer (EC) is cancer that occurs in the esophagus — a long, hollow tube that runs from your throat to your stomach. Squamous cell cancer (SCC) comprised the vast majority of esophageal cancers globally.
Lung Cancer (LC)
Lung cancer (LC) is a type of cancer that begins in the lungs. Lung cancers usually are grouped into two main types called small cell and non-small cell.
Cervical Cancer (CC)
Cervical cancer (CC) is a type of cancer that occurs in the cells of the cervix. It is mostly caused by HPV infections. The metastasis can occur in liver, lung or bone.
Leukemia
Leukemia is a group of blood cancers that usually begin in the bone marrow and result in high numbers of abnormal blood cells. There are many subtypes of leukemia such as AML, CLL and SLL.
Solid Tumors
Each cancer has a unique biomarker pattern and defining the biomarker pattern of your cancer is almost crucial for the treatment method you need to have.
Pediatric Cancer
Cancers that occur between birth and 14 years of age are considered childhood cancer. Most common types of cancer in children are brain cancer and neuroblastoma, leukemia, and lymphoma.
Multiple Myeloma (MM)
Multiple myeloma (MM), also known as Kahler's disease, is an uncommon blood cancer that affects the bone marrow, the body's blood-forming system, and can lead to kidney problems.
